SUVITRA

This brand name is authorized in Nigeria.

Active ingredients

The drug SUVITRA contains one active pharmaceutical ingredient (API):

1	Levetiracetam UNII 44YRR34555 - LEVETIRACETAM
	Levetiracetam, is a pyrrolidone derivative, chemically unrelated to existing antiepileptic active substances. Levetiracetam induces seizure protection in a broad range of animal models of partial and primary generalised seizures without having a pro-convulsant effect. The primary metabolite is inactive.
	Read more about Levetiracetam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7250	Tablet	Suvitra-500 Tablets TAB 500 mg 3 x 10's (in Alu-Alu blisters)	Film Coated Tablet Blue-colored, oblong-shaped, film-coated tablets with "MICRO" engraved on one surface break line on other surface	03/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AX14	Levetiracetam	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7250